Lipid Biology Laboratory

Chief Scientist

Toshihide Kobayashi

  • Ph.D.
  • Toshihide Kobayashi
  • Brief resume
    1983
    Ph.D., University of Tokyo
    1999
    Team Leader, Sphingolipid Functions Laboratory, RIKEN
    2003
    Chief Scientist, Lipid Biology Laboratory, RIKEN (-current)
    2007
    Professor, Graduate School of Science and Engineering, Saitama University (-current)

Outline

Lipid Biology Laboratory

Whereas the bilayer organization of biomembranes can be reconstituted in artificial liposomes with a simple lipid composition, biomembranes contain thousands of different lipid species. The relative abundance of these lipids moreover varies from one organelle to another. Also from one leaflet to another, within the same bilayer, the distribution is asymmetric. Even more striking is the lateral segregation of lipids within the same leaflet.

This complex distribution of lipids suggests that the targeting of lipids is highly regulated and that cells require complex supramolecular lipid organization within membranes. One attractive proposal is that the formation of membrane domains is promoted by purely physical interactions between lipids and proteins. In this context, the idea of transient raft-like microdomain formation by clustering of sphingolipid and cholesterol has drawn much attention.

The aim of our laboratory is to elucidate the molecular mechanisms of the assembly and the dynamics of lipids and lipid domains via visualizing lipid molecules and to uncover the principle of the establishment of biomembranes.

Recent Research Topic

Revisiting lipid rafts

Mode of interaction of lysenin to lipid membranes
Fig. 1 Mode of interaction of lysenin to lipid membranes
Liposomes were prepared using sphingomyelin (SM) and “fluid” phosphatidylcholine (dioleoyl phosphatidylcholine, DOPC) (upper row) or “rigid” phosphatidylcholine (dipalmitoyl phosphatidylcholine, DPPC) (lower row) and the binding of GFP-lysenin (Venus-lysenin) was examined (right). Venus-lysenin binds SM in fluid but not in rigid phosphatidylcholine membrane. In fluid membrane, SM forms clusters (upper row, center). In the center photo, red represents rigid membrane containing SM whereas green shows the fluid membrane rich in DOPC. The left picture schematically indicates the formation of sphingomyelin-rich cluster in orange. In rigid DPPC membrane, SM and DPPC are mixed well and therefore SM is dispersed in the membrane (lower row, left and center).
Heterogeneity of plasma membrane lipid domainsHeterogeneity of plasma membrane lipid domains
Fig. 2 Heterogeneity of plasma membrane lipid domains
Jurkat cells were doubly labeled with non-toxic lysenin (HmV-NT-Lys) and cholera toxin B subunit (CTxB). Plasma membranes were uniformly labeled under a fluorescence microscope (upper left). However, under an electron microscope, lysenin domain (at left, labeled with 5 nm gold; colored red at right) and cholera toxin domain (labeled with 10 nm gold; colored blue) were differently distributed. (Below) Ripley's K-function indicates lysenin (labels sphingomyelin) and cholera toxin (labels ganglioside GM1) form domains, whereas a co-cluster of GM1 and sphingomyelin is not formed.

Biomembranes contain thousands of lipid species. These lipids are not randomly distributed in the membrane; rather, it is speculated that nanometer scale domains that contain specific lipids play a crucial role in cellular function. One (and in many cases only one) of the rationales of this hypothesis is the observation that the nanoscale distribution of specific proteins is affected by altering cellular cholesterol content. A few successful examples of direct observation of the lipid distribution by electron microscopy using lipid-specific proteins support the heterogeneous distribution of lipids on the cell membranes. However, the molecular events which underlie “cholesterol sensitivity” are not well known. Studies on red blood cells revealed the asymmetric lipid distribution between the outer and inner leaflets of the plasma membrane. However, the biochemical analysis of lipid asymmetry, which has been used to study lipid asymmetry in red blood cells, is applicable to only a limited number of membrane samples.

In order to understand lipid nanodomains, we need to clarify the dynamics of lipids in the outer and inner leaflets of the membrane at the nanometer scale. Our knowledge of lipid nanodomains is limited, and the elucidation of lipid domains relies only on the careful observation of lipids. The development of new tools and new methods is required for this purpose.

We have been studying lipid specific antibodies, toxins, peptides and low molecular weight compounds in order to visualize lipids. Interactions of these molecules with lipids are not simple. The recognition of lipids is dependent on different factors such as the organization of lipids, membrane curvature, etc. The earthworm-derived toxin, lysenin, specifically binds to sphingomyelin clusters (Fig. 1). In Fig. 2, we showed that there are two different lipid domains on the plasma membrane using lysenin and cholera toxin, which binds glycolipid GM1.

Lipid rafts are well-studied lipid domains which are composed of sphingolipids and cholesterol. Cholesterol plays a crucial role in the formation and maintenance of lipid rafts. We found that poly(ethylene glycol) cholesterol ether (PEG-Chol) is a low molecular weight, low toxicity probe for cholesterol. Although cholesterol is distributed both in the outer and inner leaflets of the plasma membrane, PEG-Chol is restricted to the outer layer because of the bulk PEG moiety of the molecule. Thus, PEG-Chol is used to follow the internalization cholesterol-rich membrane domains on the outer leaflet of the plasma membrane.

In addition to PEG-Chol, the antibiotic filipin and sterol-binding toxins are known as cholesterol tracers. The cholesterol concentrations of the membrane required for filipin binding and toxin binding are different. This makes it possible to estimate cholesterol concentration in the biomembranes using these two cholesterol probes.

Only a limited number of molecules are known to bind specific lipids. The discovery of new probes for lipids or lipid domains is undoubtedly useful to understand the detailed structure of lipid nanodomains. It is also important to develop methods to follow lipid dynamics without using lipid probes.

Selected Publications

  1. M. Abe, et al. A role for sphingomyelin-rich lipid domains in the accumulation of phospatidylinositol-4,5-bisphosphate to the cleavage furrow during cytokinesis, Mol. Cell. Biol. 2012, in press.
  2. H-H. Tan, A. Makino, K. Sudesh, P. Greimel, T. Kobayashi, Spectroscopic evidence for the unusual stereochemical configuration of an endosome-specific lipid, Angew. Chem. Int. Ed. Engl. 2012, 51, 533.
  3. R. Ishitsuka, T. Saito, H. Osada, Y. Ohno-Iwashita, T. Kobayashi, Fluorescence image screening for chemical compounds modifying cholesterol metabolism and distribution. J. Lipid Res. 2011, 52, 2084.
  4. M. Murate, et al. Phosphatidylglucoside forms specific lipid domains on the outer leaflet of the plasma membrane, Biochem. 2010, 49, 4732.
  5. T. Hayakawa, et al. pH-dependent formation of membranous cytoplasmic body-like structure of ganglioside GM1/bis(monoacylglycero)phosphate mixed membranes, Biophys. J. 2007, 92, L13.
  6. M. Takahashi, et al. Cholesterol controls lipid endocytosis through Rab11, Mol. Biol. Cell 2007, 18, 2667.
  7. K. Iwamoto, et al. Curvature-dependent recognition of ethanolamine phospholipids by duramycin and cinnamycin, Biophys. J. 2007, 93, 1608.
  8. F. Hullin-Matsuda, et al. De novo biosynthesis of the late endosome lipid, bis(monoacyl- glycero)phosphate, J. Lipid Res. 2007, 48, 1997.
  9. E. Kiyokawa, et al. Spatial and functional heterogeneity of sphingolipid-rich membrane domains, J. Biol. Chem. 2005, 280, 24072.
  10. R. Ishitsuka, A. Yamaji-Hasegawa, A. Makino, Y. Hirabayashi, T. Kobayashi, A lipid-specific toxin reveals heterogeneity of sphingomyelin-containing membranes, Biophys. J. 2004, 86, 296.
  11. S. Sato, et al. Distribution and transport of cholesterol-rich membrane domains monitored by a membrane-impermeant fluorescent polyethylene glycol-derivatized cholesterol, J. Biol. Chem. 2004, 279, 23790.
  12. A. Yamaji-Hasegawa, et al. Oligomerization and pore formation of a sphingomyelin-specific toxin, lysenin, J. Biol. Chem. 2003, 278, 22762.

Core Members

Principal Investigator add delete
Toshihide Kobayashi Chief Scientist    
Staff Scientist add delete
Akiko Hasegawa-Yamaji Senior Research Scientist    
Reiko Ishitsuka Senior Research Scientist    
Taro Yamada Senior Research Scientist    
Peter Greimel Research Scientist    
Mitsuhiro Abe Research Scientist    
Postdoctoral Fellow add delete
Takuma Kishimoto Special Postdoctoral Researcher    
Takehiko Inaba Special Postdoctoral Researcher    
Motohide Murate Contract Researcher    
Nario Tomishige Contract Researcher    
Asami Makino Postdoctoral Researcher    
Neval Yilmaz Postdoctoral Researcher    
Shota Sakai Postdoctoral Researcher    
Student Trainee add delete
Yasunori Uchida Junior Research Associate    
Hema Balakrishna Bhat International Program Associate    
Hui Hui Tan International Program Associate    
Technical Assistant add delete
Yukiko Senoh Technical Staff I    
Administrative Assistant add delete
Visiting Research Staff add delete
Other Staff add delete
Back to Top